Cognizant

CTSH · NYSE · Technology · United States

Financials at a glance

Source: SEC XBRL

Annual

FY2023FY2024FY2025$19.4B$19.4B$19.7B$19.7B$21.1B$21.1B10.6% margin10.6% marginRevenueNet margin

Quarterly · last 8

Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26$4.9B$4.9B$4.8B$4.8B$4.8B$4.8B$5.0B$5.0B$5.1B$5.1B$5.2B$5.2B$5.4B$5.4B$5.4B$5.4B12.2% margin12.2% marginRevenueNet margin

Revenue (FY2025)

$21.1B

Net margin

10.6%

ROE

14.9%

Revenue CAGR (2y)

+4.4%

Profit CAGR (2y)

+2.4%

EPS (FY2025)

4.56

Net profit (FY2025)

$2.2B

Ask MarketChacha about CTSH

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

  • Jul 28, 2026

    Cognizant shares rose sharply after the company announced the launch of its new EMEA AI Unit on July 28 to help enterprises scale agentic AI adoption.

    source 1 ↗source 2 ↗· confidence: high
  • Jul 24, 2026

    No specific company catalyst or filing explains the move; Cognizant shares rose amid valuation appeal after a steep YTD decline, with earnings not due until July 29.

    · confidence: low

Daily moves with the verified reason behind them. Education only — not investment advice.

On MarketChacha

Posts about CTSH

Financials

Yearly

PeriodRevenueNet profitEPSNet marginROE
FY2025$21.1B$2.2B4.5610.6%14.9%
FY2024$19.7B$2.2B4.5111.3%15.5%
FY2023$19.4B$2.1B4.2111.0%16.1%

Quarterly

PeriodRevenueNet profitEPSNet margin
2026Q1$5.4B$662.0M1.3912.2%
2025Q3$5.4B$274.0M0.565.1%
2025Q2$5.2B$645.0M1.3112.3%
2025Q1$5.1B$663.0M1.3413.0%
2024Q3$5.0B$582.0M1.1711.5%
2024Q2$4.8B$566.0M1.1411.7%
2024Q1$4.8B$546.0M1.1011.5%
2023Q3$4.9B$525.0M1.0410.7%
2023Q2$4.9B$463.0M0.919.5%
2023Q1$4.8B$580.0M1.1412.1%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.